Advancing Safe, Efficacious, & Long-Lasting Delivery to the Eye

Innovating Patient-Centric, Longer-Lasting Delivery to Specific Ocular Targets to Strengthen Adherence to Transformative Ophthalmic Therapies with Enhanced Durability & Formulation

As the global burden of retinal and ocular diseases continues to rise, the race to develop safer, longer-lasting, and less invasive treatments is accelerating, and at the heart of that challenge lies drug delivery. The 4th Ophthalmic Drug Delivery Summit arrives at a pivotal moment, bringing together 80+ leading experts from pharma and biotech to tackle the toughest delivery hurdles limiting the impact of cutting-edge therapeutics.

With industry momentum building around sustained-release technologies, suprachoroidal administration, and innovative device-drug combinations, this summit is your gateway to the breakthroughs redefining ocular treatment. From translating long-acting formulations into clinical success to navigating regulatory complexities early, this is the only event dedicated to transforming how and where ophthalmic therapies work - making it a must-attend for anyone shaping the future of eye care.

I truly enjoyed the intimate nature of the conference. It allowed for great networking with people at the top of the field as well as those just entering it.

Chemistry, Manufacturing & Controls Program Management Manager, Regeneron Pharmaceuticals  

Regeneron Pharmaceuticals

Excellent line-up of industry experts. Very engaging and innovative content.

Senior Manager, R&D Engineering Team Leader, Teva Pharmaceuticals 

Teva Pharmaceuticals 

The people attending the meeting were the world experts on the topic.

Co-Founder & Chief Innovation Officer, Aviceda Therapeutics

Aviceda Therapeutics

Explore the Full Event Guide

  • 3 Days Dedicated to Ocular Drug Delivery Innovation 
  • 22+ Expert Speakers Across Pharma, Biotech, & Academia
  • Exclusive Networking with Leading Ocular R&D Decision-Makers 
  • Insights from Delivery Scientists & Formulation Specialists to Regulatory Experts
  • Real-World Case Studies from Industry Giants & Emerging Innovators 
brochure cover

What To Expect

80+

Attendees from Ocular Delivery 

22+

World-Class Speakers

12+

Hours of in-Person Networking

2

Tracked Pre-Conference Workshop Day

1

Exclusive Ophthalmic Drug Delivery Event 

Attending Companies Include

Regeneron
Boehringer Ingelheim
Johnson & Johnson
AbbVie
Lineage Cell Therapies
Ocugen
Perfuse Therapeutics
Screenshot-2025-08-12-093824-768x506
Explore the Agenda

Discover the latest innovations transforming ocular drug delivery, from long-acting implants to suprachoroidal access. 

Screenshot-2025-08-12-093745-768x501
Partner With Us

Connect with top-tier drug developers actively seeking expert collaborators across formulation, devices, imaging, and more. 

Screenshot-2025-08-12-093857-768x507
Join Other Ocular Delivery Experts

Register now and look forward to networking with 80+ leading scientists and innovators advancing the future of ophthalmic therapeutics.